---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-002171"
form_type: "8-K"
ticker: "CCTC"
cik: "0001477960"
company_name: "LataMed AI Corp."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:33:43.918079+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Catalyst Crew acquires AI healthcare IP and Venezuelan subsidiary from CEO in related-party transactions

## Summary
- Acquired AI healthcare analytics IP (CardioAI, PulmoAI, NeuroAI) from CEO via APA dated Feb 17, 2026.
- Acquired 100% of Inversiones Long 33, C.A. from CEO on March 23, 2026; now wholly-owned subsidiary.
- IP formally assigned to subsidiary on April 7, 2026 as internal reorganization; no additional consideration.
- Press releases issued March-April 2026 announcing CardioAI, PulmoAI, NeuroAI platforms and operating structure.

## SEC filing metadata
- accession: 0001477932-26-002171
- form_type: 8-K
- ticker: CCTC
- cik: 0001477960
- company_name: LataMed AI Corp.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477960/000147793226002171/0001477932-26-002171-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477960/000147793226002171/cctc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-002171
- JSON: https://secwatch.observer/filing/0001477932-26-002171.json
- Plain text: https://secwatch.observer/filing/0001477932-26-002171.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
